This announcement is a separate document:
北京市中伦（深圳）律师事务所关于灵康药业集团股份有限公司2024年第二次临时股东大会的法律意见书
Legal opinion of Zhong Lun (Shenzhen) Law Firm on Lionco Pharmaceutical Group's second extraordinary general meeting of shareholders in 2024 in Peking.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated